Navigation Links
ObeTherapy Announces the Publication of Results Obtained with one of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes
Date:12/4/2012

sure of eating while losing weight, greatly facilitating the changes in personal habits that may be required for a long-term solution to their condition.

The CEO and founder of the Company, Dr. Itzik Harosh, explained that enteropeptidase is a peripheral enzyme localized on the epithelial surface of the duodenum. This constitutes a major advantage over a systemic target, in that an inhibitor needs not be absorbed to express its activity, minimizing the probability of toxicity and side effects. This new approach of identification new targets based on «lean or starvation phenotype» should open new avenues in obesity and diabetes drug discovery.

A novel, orally administered enteropeptidase inhibitor shows very promising results in vivo. This compound is a pseudopeptide with negligible bioavailability.  Furthermore, if injected directly in the bloodstream, it is destroyed and cleared within minutes.  Few, if any, side effects are thus anticipated.

Professor Marco A. Ciufolini, of the University of British Columbia at Vancouver, and a consultant in synthetic chemistry for Obetherapy, indicated that the inhibitor in question can be manufactured on large scale after only minor modifications of the current route. 

Dr. Harosh declared that these results should promote the development of the company and assist ObeTherapy in establishing new collaborations and fund raising.

Obetherapy Biotechnology is a company specializing in the research and development of new drugs for the treatment of obesity, hypercholesterolemia, and type II diabetes. It is localized on the Génopôle® campus, in Evry, France.  Unlike its competitors, who concentrate on the genetic characterization of obesity, ObeTherapy follows an innovative approach that centers on the analysis of individuals with a "lean" phenotype. The Company is especially interested in the study of patients suffering from rare monogenic diseases character
'/>"/>

SOURCE ObeTherapy Biotechnology
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 Arbor Pharmaceuticals, LLC. - Product ... Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - Product Pipeline ... Arbor Pharmaceuticals, LLC.,s pharmaceutical research and development focus. ... current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.,s, ... assessment by drug target, mechanism of action (MoA), ...
(Date:9/30/2014)...  Decision Resources Group finds that the Asia Pacific ... China , India , ... through 2023. Dental implant procedure volumes will grow as physicians are ... Other key findings from Decision Resources Group,s coverage of the ... , Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... , Sept. 30, 2014  Alimera Sciences, Inc. ... that specializes in the research, development and commercialization of ... a $25 million advance from Hercules Technology Growth Capital, ... is the second and final advance under the Loan ... United Kingdom , Alimera Sciences Limited, entered ...
Breaking Medicine Technology:Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2
... International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG ... marketer of innovative medical devices for interventional cardiology and ... third fiscal quarter (" Q3 FY12 ") and nine ... Q3 FY12 Performance Highlights: ...
... Misonix, Inc. (NASDAQ: MSON ), ... markets innovative therapeutic ultrasonic products worldwide for wound ... surgical and medical applications, today reported financial results ... ending December 31, 2011.  Michael A. McManus Jr., ...
Cached Medicine Technology:Biosensors Reports Continued Strong Sales and Earnings Growth in the Third Quarter of Fiscal Year 2012 2Biosensors Reports Continued Strong Sales and Earnings Growth in the Third Quarter of Fiscal Year 2012 3Biosensors Reports Continued Strong Sales and Earnings Growth in the Third Quarter of Fiscal Year 2012 4Biosensors Reports Continued Strong Sales and Earnings Growth in the Third Quarter of Fiscal Year 2012 5Biosensors Reports Continued Strong Sales and Earnings Growth in the Third Quarter of Fiscal Year 2012 6Misonix Reports a 29% and 24% Increase in Revenue for the Second Quarter and Six Months Fiscal 2012 Financial Results 2Misonix Reports a 29% and 24% Increase in Revenue for the Second Quarter and Six Months Fiscal 2012 Financial Results 3Misonix Reports a 29% and 24% Increase in Revenue for the Second Quarter and Six Months Fiscal 2012 Financial Results 4Misonix Reports a 29% and 24% Increase in Revenue for the Second Quarter and Six Months Fiscal 2012 Financial Results 5Misonix Reports a 29% and 24% Increase in Revenue for the Second Quarter and Six Months Fiscal 2012 Financial Results 6
(Date:10/1/2014)... 2014 Insuranceragents.info has released a ... life insurance plan for vulnerable family members. , Life ... members. Providers in the family should always carry a ... hardships for the rest of the family. , ... can benefit more from temporary coverage or from a ...
(Date:10/1/2014)... and ATLANTA (PRWEB) October 01, 2014 ... security executive networking and relationship-marketing firm, announced ... Information Security Executive® and Project of the ... top-ranking decision makers representing organizations in financial ... Projects include large-scale technology endeavors that address ...
(Date:10/1/2014)... 2014 Between 23 million and 50 ... according to figures from the National Institutes of Health ... and many of them have something else in common: ... celiac disease. Gluten Free Therapeutics, makers of CeliVites ... celiac disease by publishing a series of blog posts ...
(Date:10/1/2014)... 2014 Scientists at the University of ... target immune system proteins has the power to knock ... details of the new study on their website. ... Researchers in the UWA School of Pathology and Laboratory ... mice with mesothelioma with promising results. , “A ...
(Date:10/1/2014)... Woodland Hills dental implants ... of dental specialists who treat full mouth implant cases ... Oviedo. Dr. Reshad of the Anacapa Dental Art Institute, ... two continents, will give a full-day presentation Oct. 4 ... , “These specialists want to improve their skills and, ...
Breaking Medicine News(10 mins):Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4
... Coverage Continues to Drop Even Before the,Economic Downturn in ... Exceeds the Combined,Population of 24 States Plus the District ... Bureau,s annual,report released today shows that the number of ... continued worsening of health,coverage for America,s workers., While ...
... study could explain why "daddy" and "mommy" are often ... be hard-wired to recognize certain repetition patterns. , ... British Columbia post-doctoral fellow Judit Gervain and a team ... of 22 newborns (2-3 days old) when exposed to ...
... 26 WaterPure,International, Inc. (the "Company" or "WaterPure") ... executed an amended Atmospheric Water,Generator (AWG) patent license ... of the original license. Under the previous agreement,WaterPure ... in the current,year. The revised terms now call ...
... both the SIRIUS and XM services on SIRIUS, Hits 1 SIRIUS channel 1 ... ... channel 24, NEW YORK, Aug. 26 SIRIUS XM ... Campaign to broadcast its "Just Stand Up" national,fundraising event live on Friday, September ...
... Sciences Inc. today,announced the development of their ... medical devices that release drugs at,constant rates ... has already been used,by Particles Sciences to ... polymeric materials often follows a burst/first-order kinetic ...
... of Alberta in Edmonton, Canada, shows thatfor womenthe caffeine advantage ... don,t drink coffee can get just as much of a ... a study in the latest edition of Nutrition Research ... you are hooked on caffeine or not, if you need ...
Cached Medicine News:Health News:Number of Uninsured Decreased in 2007 But Census Report Shows Growing Health Coverage Problems 2Health News:UBC scientist unveils secret of newborn's first words 2Health News:WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air 2Health News:SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star-Studded 'Just Stand Up' Fundraising Event on September 5 2Health News:SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star-Studded 'Just Stand Up' Fundraising Event on September 5 3Health News:SIRIUS XM Radio Joins Stand Up To Cancer Campaign with Live Broadcast of Star-Studded 'Just Stand Up' Fundraising Event on September 5 4Health News:Particle Sciences Develops Zero-Order-Release Combination Device Technology 2Health News:Java gives caffeine-naive a boost, too 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: